-

QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI), a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, updated the ticker symbol for its warrants to “QTIWW”, currently trading in the over-the-counter (OTC) market, effective as of March 11, 2024. The company’s units formerly trading in the OTC market under “GIAFU” have been delisted as of March 11, 2024, as each unit was split into one share of common stock and one warrant upon the closing of its business combination on March 4, 2024.

About QT Imaging Holdings, Inc.

QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.

Contacts

For media inquiries, please contact:
Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com

QT Imaging Holdings, Inc.

NASDAQ:QTI

Release Versions

Contacts

For media inquiries, please contact:
Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com

More News From QT Imaging Holdings, Inc.

QT Imaging Reports Strong Third Quarter 2025 Financial Results

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the three and nine months ended September 30, 2025, and provided a business update. “I am pleased to report that our team delivered another strong performance,” said Dr. Raluca Dinu, QT Imaging Chief Executive Officer. “This quarter’s res...

Accomplished Industry Veteran, Satrajit Misra, Joins QT Imaging as Chief Commercial Officer

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (OTCQB: QTIH), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, is pleased to announce the appointment of Satrajit Misra as the Company’s Chief Commercial Officer (“CCO”). Mr. Misra’s appointment underscores QTI’s commitment to innovation, clinical excellence, and commercial execution in delivering accessible, radiation-free...

QT Imaging to Report Third Quarter 2025 Financial Results on November 11 – Webcasted Conference Call to Follow

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (OTCQB: QTIH), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will release its third quarter 2025 financial results after market close on Tuesday, November 11, 2025. Following the announcement, QT Imaging management will host a webcasted conference call to review the financial results and provide a...
Back to Newsroom